Metis Technologies
Latest round
- Series D
Last raised
- Aug 2025
Total raised
- $5.6M
Investors
- 2
About Metis Technologies
Metis Technologies, based in Beijing, China, is a biotechnology company focused on developing innovative AI-driven nano-materials for advanced drug delivery systems.Founded in 2020, Metis Technologies specializes in the biopharmaceutical sector, offering AI-enhanced solutions for targeted drug delivery.Metis Technologies specializes in innovative AI-driven nano-materials designed for targeted delivery systems. Their core product, the AiLNP platform, leverages artificial intelligence to optimize lipid nanoparticle (LNP) delivery systems, primarily utilized in biopharmaceutical applications, including oncology and regenerative medicine. The company plans to launch new products targeting specific therapeutic areas and expand its market presence into additional regions by the end of 2026.
Who invested in Metis Technologies
2 investors across 1 round
See all investors in Metis Technologies
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series D
Aug 4, 2025
Amount
$5.6M
Investors
Questions about Metis Technologies
Who invested in Metis Technologies?
Metis Technologies has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Metis Technologies raised?
Metis Technologies has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Metis Technologies last raise money?
Metis Technologies's most recent round on record is a Series D, in Aug 2025.
What does Metis Technologies do?
Metis Technologies, based in Beijing, China, is a biotechnology company focused on developing innovative AI-driven nano-materials for advanced drug delivery systems.
Where is Metis Technologies headquartered?
Metis Technologies is headquartered in Beijing, China.
Which VCs invest in companies like Metis Technologies?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, Taibao Capital and Hengxu Capital back healthcare companies at Metis Technologies's stage. Their profiles are linked below.
VCs backing healthcare startups at Series D
Raising like Metis Technologies? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.